News

Filter

Current filters:

Invega

1 to 9 of 31 results

Johnson & Johnson’s Invega first antipsychotic for schizoaffective disorder approved in EU

05-01-2011

Belgium-based Janssen-Cilag International, part of US health care giant Johnson & Johnson (NYSE: JNJ),…

EuropeInvegaJanssen-CilagJohnson & JohnsonNeurologicalPharmaceuticalRegulation

J&J seeking to enlarge paliperidone franchise

16-02-2009

US health care major Johnson & Johnson has submitted two supplemental New Drug Applications to the Food…

Amino AcidsInjectionInvegaJohnson & JohnsonPaliperidonePhysostigmine SalicylateRisperdalRisperdal ConstaRisperidone

Janssen withdraws EU application for Invega

15-01-2009

Janssen-Cilag, a subsidiary of US health care major Johnson & Johnson, has withdrawn its application…

InvegaJanssen-CilagJohnson & JohnsonPaliperidone

1 to 9 of 31 results

COMPANY SPOTLIGHT

Menarini

Back to top